Company Description
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.
The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds.
Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software.
Spectral AI, Inc. is headquartered in Dallas, Texas.
| Country | United States |
| Founded | 2013 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 78 |
| CEO | Vincent Capone |
Contact Details
Address: 2515 McKinney Avenue, Suite 1000 Dallas, Texas 75201 United States | |
| Phone | 972 499 4934 |
| Website | spectral-ai.com |
Stock Details
| Ticker Symbol | MDAI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1833498 |
| CUSIP Number | 84757T105 |
| ISIN Number | US84757T1051 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Wensheng Fan | Co-Founder, Chief Innovation Strategist and Senior Advisor to the Chief Executive Officer |
| Vincent Stanley Capone Esq. | Chief Executive Officer, Chief Financial Officer, General Counsel and Corporate Secretary |
| Dr. John Michael DiMaio M.D. | Founder and Chairman |
| Stanley Micek | Chief Operating Officer |
| Louis Percoco | General Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 11, 2026 | SCHEDULE 13G | Filing |
| Feb 10, 2026 | 8-K | Current Report |
| Feb 3, 2026 | 8-K | Current Report |
| Jan 6, 2026 | 8-K | Current Report |
| Nov 13, 2025 | 10-Q | Quarterly Report |
| Oct 30, 2025 | S-3 | Registration statement under Securities Act of 1933 |
| Oct 24, 2025 | 8-K | Current Report |
| Oct 23, 2025 | 424B5 | Filing |
| Aug 14, 2025 | SCHEDULE 13G/A | Filing |
| Aug 13, 2025 | 8-K | Current Report |